Severe chronic kidney disease is associated with poor survival after initial CRT-defibrillator tachyarrhythmia therapy.

Evan C Adelstein Samir F SabaSandeep JainNorman C Wang

Published in: Pacing and clinical electrophysiology : PACE (2019)

Survival after appropriate tachyarrhythmia therapies, particularly shocks, is attenuated in patients with GFR ≤30. This raises concern over potential lack of survival benefit conferred by CRT-defibrillators versus CRT-pacemakers in this population.

Keyphrases

cardiac resynchronization therapy
left ventricular
chronic kidney disease
heart failure
end stage renal disease
early onset
human health
mesenchymal stem cells